CLINICAL_TRIALS
trial_result
· 2023-09-18
Clinical Trial Update: Open Label Ketamine Treatment for Major Depressive Disorder in Veterans [Phase 2]
Summary
Phase 2 open-label trial evaluating ketamine treatment for major depressive disorder in veterans has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Connecticut Healthcare System | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED